Clinical Trials

Please contact the Clinical Research Coordinator at (617) 636-4941 for more information about these trials. These trials take place at Tufts Medical Center, 800 Washington Street, Boston, MA 02111.

Funding Agent Title Status
National Institute of Health (NIH) A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and Patient-Reported Outcomes in Pediatric and Adult Patients with Eosinophilic Esophagitis (EoE), Gastritis (EG) and Colitis (EC) Closed to enrollment
National Institute of Health (NIH) Six Food vs One Food Eosinophilic Esophagitis Elimination Diet (SOFEED) followed by Swallowed Glucocorticoid Trial Closed to enrollment
Merck Sharp & Dohme Corp A Phase III, Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-3641, a Ragweed (Ambrosia artemisiifolia) Sublingual Immunotherapy Tablet, in Children With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma Closed to enrollment
Shire Inc. Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects
(11 to 55 Years of Age, Inclusive) with Eosinophilic Esophagitis:
A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Closed to enrollment
Adare Pharmaceuticals FLUTicasone in Eosinophilic esophagitis (FLUTE) A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects with Eosinophilic Esophagitis Closed to enrollment
Allakos, Inc. A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients with Eosinophilic Gastritis with or without Eosinophilic Gastroenteritis Closed to enrollment
Shire Inc. An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents with Eosinophilic Esophagitis (EoE). Closed to enrollment
Shire Inc. Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE). Enrolling those who have completed SHP621-301 study
Allakos, Inc. An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis. Enrolling those who have completed AK002-003 study